Hideki Hayakawa - Concepedia

Author

Hideki Hayakawa

Also Known As

Akiko Matsudo, Daichi Wakebe, H HAYAKAWA, H Hayakawa, H. Hayakawa, Hayakawa, Hideki, Hideki HAYAKAWA, Hideki Hayakawa, Hideki Hayakawa (818823), Hirokazu Hayakawa

127

Publications

3.3K

Citations

H-Index

200

Concepts

All Affiliations

The University of Osaka Juntendo University Kitasato University The University of Tokyo Osaka Gas (Japan)

About

Hideki Hayakawa is an author at The University of Osaka specializing in medicine, neuroscience, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	22	1.1K
2	Engineering	11	12	771
3	Natural Sciences	5	5	227
4	Health Sciences	2	2	51
5	Public Health	1	1	11

Hideki Hayakawa

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue Yoichi Imaizumi, Yohei Okada, Wado Akamatsu, Molecular Brain	2012	382
Photometric stereo under a light source with arbitrary motion Hideki Hayakawa Journal of the Optical Society of America A EngineeringComputational IlluminationLaboratory ExperimentOptical System AnalysisIllumination Modeling	1994	274
An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease Hideki Mochizuki, Hideki Hayakawa, Makoto Migita, Proceedings of the National Academy of Sciences Vector DeliveryAdeno-associated VirusMedicineApoptosisAntiviral Drug Development	2001	162
A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo Masayuki Nakamori, Gagan B. Panigrahi, Stella Lanni, Nature Genetics ChromatinGenome InstabilitySignal TransductionNatural SciencesOligonucleotide	2020	145
Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein Katsuya Araki, Naoto Yagi, Koki Aoyama, Proceedings of the National Academy of Sciences	2019	143
Caspase-11 Mediates Inflammatory Dopaminergic Cell Death in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's Disease Tsuyoshi Furuya, Hideki Hayakawa, M. Yamada, Journal of Neuroscience MitophagyMitochondrial DysfunctionImmunology1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse ModelCell Death	2004	139
A forward-inverse optics model of reciprocal connections between visual cortical areas Mitsuo Kawato, Hideki Hayakawa, Toshio Inui Network Computation in Neural Systems EngineeringFeedforward ConnectionSocial SciencesEarly VisionVisual Cognition	1993	129
Alternative mitochondrial quality control mediated by extracellular release Chi‐Jing Choong, Tatsusada Okuno, Kensuke Ikenaka, Autophagy	2020	113
[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease Shizuo Hatashita, Hidetomo Yamasaki, Yutaka Suzuki, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyNeuroimaging BiomarkersNeurodegenerative DiseasesAlzheimer's DiseaseMedicine	2013	111
Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant Rieko Setsuie, Yu-Lai Wang, Hideki Mochizuki, Neurochemistry International Knockout MouseMolecular NeuroscienceGeneticsDegenerative PathologyNeuroscience	2006	103

Page 1